If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea Anichini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells

    Perotti, V., Baldassari, P., Molla, A., Nicolini, G., Bersani, I., Grazia, G., Benigni, F., Maurichi, A., Santinami, M., Anichini, A. & Mortarini, R., May 30 2019, In : Oncogene. 38, 22, p. 4384-4396 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • Antibody-Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non-small cell lung cancer subsequent to PD-1/PD-L1 blockade

    Russo, G. L., Moro, M., Sommariva, M., Cancila, V., Boeri, M., Centonze, G., Ferro, S., Ganzinelli, M., Gasparini, P., Huber, V., Milione, M., Porcu, L., Proto, C., Pruneri, G., Signorelli, D., Sangaletti, S., Sfondrini, L., Storti, C., Tassi, E., Bardelli, A. & 9 others, Marsoni, S., Torri, V., Tripodo, C., Colombo, M. P., Anichini, A., Rivoltini, L., Balsari, A., Sozzi, G. & Garassino, M. C., 2019, In : Clinical Cancer Research. 25, 3, p. 989-999 11 p.

    Research output: Contribution to journalArticle

    Guadecitabine plus ipilimumab in unresectable melanoma: The NIBIT-M4 clinical trial

    Di Giacomo, A. M., Covre, A., Finotello, F., Rieder, D., Danielli, R., Sigalotti, L., Giannarelli, D., Petitprez, F., Lacroix, L., Valente, M., Cutaia, O., Fazio, C., Amato, G., Lazzeri, A., Monterisi, S., Miracco, C., Coral, S., Anichini, A., Bock, C., Nemc, A. & 7 others, Oganesian, A., Lowder, J., Azab, M., Fridman, W. H., Sautes-Fridman, C., Trajanoski, Z. & Maio, M., 2019, In : Clinical Cancer Research. 25, 24, p. 7351-7362 12 p.

    Research output: Contribution to journalArticle

    Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial

    Di Giacomo, A. M., Covre, A., Finotello, F., Rieder, D., Danielli, R., Sigalotti, L., Giannarelli, D., Petitprez, F., Lacroix, L., Valente, M., Cutaia, O., Fazio, C., Amato, G., Lazzeri, A., Monterisi, S., Miracco, C., Coral, S., Anichini, A., Bock, C., Nemc, A. & 7 others, Oganesian, A., Lowder, J., Azab, M., Fridman, W. H., Sautès-Fridman, C., Trajanoski, Z. & Maio, M., Dec 15 2019, In : Clin. Cancer Res.. 25, 24, p. 7351-7362 12 p.

    Research output: Contribution to journalArticle